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Abstract  
A screen printed carbon electrode (SPCE) containing the electrocatalyst Meldola’s Blue 
(MB) has been investigated as the base transducer for a reagentless glutamate biosensor. The 
biopolymer chitosan (CHIT) and multiwalled carbon nanotubes (MWCNTs) were used to 
encapsulate the enzyme glutamate dehydrogenase (GLDH) and the co–factor nicotinamide 
adenine dinucleotide (NAD
+
). 
The biosensor was fabricated by sequentially depositing the components on the surface of the 
transducer (MB–SPCE) in a layer-by-layer process, details of which are included in the 
paper. Each layer was optimized to construct the reagentless device.  
The biosensor was used in conjunction with amperometry in stirred solution using an applied 
potential of +0.1V (vs. Ag/AgCl). Optimum conditions for the analysis of glutamate were 
found to be: temperature, 35°C; phosphate buffer, pH 7 (0.75 mM, containing 0.05 M NaCl). 
The linear range of the reagentless biosensor was found to be 7.5 µM to 105 µM, and limit of 
detection was found to be 3 µM (based on n = 5, CV: 8.5% based on three times signal to 
noise) and the sensitivity was 0.39 nA/µM (± 0.025, coefficient of variation (CV) of 6.37%, n 
= 5). The response time of the biosensor was 20 – 30 seconds.  
A food sample was analysed for monosodium glutamate (MSG). The endogenous content of 
MSG was 90.56 mg/g with a CV of 7.52%.  
The reagentless biosensor was also used to measure glutamate in serum. The endogenous 
concentration of glutamate was found to be 1.44 mM (n = 5), CV: 8.54%. The recovery of 
glutamate in fortified serum was 104% (n = 5), CV of 2.91%. 
Keywords: Amperometric glutamate biosensor, Screen-printed, Multiwalled Carbon 
Nanotubes (MWCNTs), Reagentless. 
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1. Introduction 
Glutamate is the principal excitatory neurotransmitter and a precursor for GABA, the primary 
inhibitory neurotransmitter. Deficiencies in the behaviour of neurological pathways that 
utilize glutamate and its receptors are associated with autism [1], stroke [2], Alzheimer’s 
disease [3], schizophrenia [4] and depression [5]. Glutamate is also a vital compound in 
cellular metabolism as it is associated with transamination, a key step in amino acid 
degradation, and is formed during deamination. Consequently the measurement of glutamate 
in biological fluids is of considerable interest. In addition, the widespread use of monosodium 
glutamate (MSG) in food products has led to increased interest in the use of new 
measurement methods for glutamate levels in food [6]. 
In a previous paper we have reported on an approach to glutamate biosensor development, 
based on a screen–printed biosensor incorporating a redox mediator and glutamate 
dehydrogenase (GLDH). In that approach the required enzyme cofactor, nicotinamide 
adenine dinucleotide (NAD
+
), was added into the analyte solution containing glutamate; the 
disposable biosensor was successfully applied to the analysis of serum and stock cubes [7]. 
While successful, the main drawback of this approach for a commercial biosensor is the 
requirement to add the cofactor into the sample solution.  
Carbon nanotubes (CNTs) are renowned for their unique electronic and mechanical 
properties [8]. They possess a high active surface area, excellent biocompatibility [9] and the 
ability to facilitate redox reactions with fast electron–transfer rates [10]. These abilities have 
popularised CNTs in the development of electrochemical biosensors.  
Two forms of CNT exist; single walled CNT (SWCNTs) and multi–walled CNT 
(MWCNTs). SWCNTs possess a singular graphite sheet rolled into a tube to create a 
cylindrical nanostructure, whereas MWCNT consist of several shells of cylindrical tubes. 
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Integration of redox dyes such as Meldola’s Blue (MB) into MWCNT matrices, has been 
previously demonstrated with well–defined voltammetric responses [11]–[13]. It should be 
mentioned that the electrocatalyst MB greatly reduces the over-potential for the oxidation of 
NADH [14]. 
The low solubility of unmodified MWCNTs leads to poor homogenous dispersion, thus in the 
present study the MWCNTs were suspended in a solution containing chitosan (CHIT). CHIT 
is a natural polysaccharide derived from crustaceans, which enhances enzyme stability and 
possesses good film forming properties [15], [16]. The dispersion of CNTs was possible due 
to the low pH required to solubilise the CHIT (pH < 3.0) [17], which was achieved using 
HCl. It was reported that the dispersion of MWCNTs in CHIT/HCl compared with other 
solvents gave the smallest particle sizes and resulted in the formation of a greater surface area 
without the need for functionalization.  
It has previously been reported that NAD
+
 was readily integrated into a glucose 
dehydrogenase biosensor and did not leach from the MWCNT matrix when coated onto the 
surface of a glassy carbon electrode [18]. This was achieved utilising a layer-by-layer 
assembly procedure. Other researchers have reported on the layer-by-layer immobilisation 
method using modified CNTs to immobilise glutamate oxidase [19], [20] and horse radish 
peroxidase [21]. This procedure is regarded as a simple, inexpensive and highly versatile 
method for the incorporation of components into film structures [22].  The advantages of a  
reagentless device fabricated using this approach is that it leads to a low cost biosensor which 
is convenient to use as no additional cofactor is required to be added to the sample solution 
[23], [24]. 
This paper describes the steps involved in the layer-by-layer development of a fully 
reagentless amperometric biosensor for glutamate. The strategy employed to achieve this goal 
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has involved the integration of the biological components (enzyme and cofactor) with multi–
walled carbon nanotubes (MWCNTs) on the surface of a Meldola’s Blue screen–printed 
carbon electrode (MB–SPCE). The biosensor has been applied to the determination of 
glutamate in serum sample and stock cubes.  
Based on the literature, it is believed that this is the first report on the development and 
application of a reagentless amperometric glutamate biosensor, based on GLDH and NAD
+
 
integrated with a disposable screen-printed electrode.  
2. Materials and Methods 
2.1. Chemicals and reagents 
All chemicals were of analytical grade, purchased from Sigma Aldrich, UK, except glutamate 
dehydrogenase (CAT: 10197734001) which was purchased from Roche, UK. The 75 mM 
phosphate buffer (PB) was prepared by combining appropriate volumes of tri–sodium 
phosphate dodecahydrate, sodium dihydrogen orthophosphate dihydrate and disodium 
hydrogen orthophosphate anhydrous solutions to yield the desired pH. Glutamate and 
NADH/NAD
+
 solutions were dissolved directly in 75 mM PB. Chitosan (CHIT) was 
dissolved in 0.05 M HCl (pH < 3.0) to produce a 0.05% solution following up to 10 minutes 
sonication. The multi-walled carbon nanotubes (MWCNT)/CHIT solution was prepared by 
mixing 0.6 mg of MWCNT into 300 µL solution of 0.05% of CHIT, with 15 minutes of 
sonication and stirring for 24 hours. Meldola’s Blue (MB) in solution was prepared by 
dissolving the appropriate weight in distilled water. Fetal bovine serum (FBS) (South 
American Origin, CAT: S1810–500) obtained from Labtech Int. Ltd, was used for serum 
analysis. Food samples (Beef OXO cubes) were obtained from a local supermarket.   
2.2. Apparatus 
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All electrochemical experiments were conducted with a three–electrode system consisting of 
a carbon working electrode containing MB, (MB–SPCE, Gwent Electronic Materials Ltd; Ink 
Code: C2030519P5), a Ag/AgCl reference electrode (GEM Product Code C61003P7); both 
printed onto PVC, and a separate Pt counter electrode. The area of the working electrode was 
defined using insulating tape, into a 3 x 3 mm
 
square area. The electrodes were then 
connected to the potentiostat using gold clips. Solutions, when required, were stirred using a 
circular magnetic stirring disk and stirrer (IKA® C–MAG HS IKAMAG, Germany) at a 
uniform rate. A µAutolab II electrochemical analyser with general purpose electrochemical 
software GPES 4.9 was used to acquire data and experimentally control the voltage applied to 
the SPCE in the 10 ml electrochemical cell which was used for hydrodynamic voltammetry. 
An AMEL Model 466 polarographic analyser combined with a GOULD BS–271 chart 
recorder was used for all amperometric studies. Measurement and monitoring of the pH was 
conducted with a Fisherbrand Hydrus 400 pH meter (Orion Research Inc., USA). Sonications 
were performed with a Devon FS100 sonicator (Ultrasonics, Hove, Sussex, UK). 
 
 
 
 
 
2.3. Principle of Operation of the Biosensor and Procedures 
The overall principle of operation of the biosensor is shown in Fig 2. Glutamate in solution is 
oxidised to form 2–oxoglutarate in the presence of the immobilized enzyme glutamate 
dehydrogenase (GLDH) and NAD
+
; the products NADH and NH4
+
 are formed during this 
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reaction.  NADH chemically reduces Meldola’s Blue which subsequently undergoes 
electrochemical oxidation at the electrode surface to produce the analytical response.  
2.4. Procedures 
2.4.1. Fabrication of the reagentless MWCNT–CHIT–MB/GLDH–NAD+–
CHIT/MWCNT–CHIT biosensor.  
Fabrication was carried out using a layer-by-layer approach to produce a total of three layers. 
Solutions were drop-coated onto the 3mm
2 
carbon working electrode.  Initial studies were 
performed to deduce the composition of layers 1 and 3. Figure 1 represents the layer-by-layer 
biosensor.  
Layer 1 was formed by drop coating a 10µL mixture of MWCNTs suspended in a solution 
containing 0.05% CHIT in a 0.05M HCl solution. This layer was allowed to partially dry at 
4°C under vacuum for 10 minutes.  
Layer 2 was optimised by carrying out amperometric studies with biosensors constructed 
using different mass combinations of CHIT, NAD
+
 with a fixed GLDH content of 27U 
(Table 1). This layer was allowed to dry at 4°C under vacuum for 3 hours. 
Layer 3 was formed in the same manner as Layer 1. This layer was allowed to dry at 4°C 
under vacuum for 2 hours.  
A further study into the effect of including additional MB was also performed. This was done 
by mixing in 1 µL of 0.01M MB in H2O with the MWCNTs in layers 1 and 3. For layer 2, an 
additional 1 µL of 0.01M MB in H2O was deposited at the composite surface. Biosensors 
were stored under a vacuum at 4°C when not in use. A photograph of the final biosensor is 
provided in the supplementary material (supplementary figure 5).  
2.4.2. Hydrodynamic Voltammetry 
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Hydrodynamic voltammetry was performed using the complete biosensor with 400 µM of 
glutamate,  in 0.75 mM phosphate buffer (pH 7.0) containing 50mM NaCl , in order to 
enzymatically generate NADH so as to establish the optimum operating potential for the 
amperometric determination of glutamate in food and serum samples. An initial potential of   
-120mV was applied to the biosensor and the resulting steady state current was measured; the 
potential was then changed to -115mV and again a steady state current was measured. The 
procedure was continued by changing the potential by 50mV steps to a potential of +100mV, 
with subsequent steps increasing by 25mV up to a final potential of +150mV. The steady 
state currents were measured at each potential, then a hydrodynamic voltammogram was 
constructed by plotting the steady state currents against the corresponding potentials.   
2.4.3. Optimisation studies with the proposed biosensor using amperometry in 
stirred solution. 
All amperometric measurements were performed with stirred 10mL solutions of 75mM PB 
pH 7.0 with 50mM NaCl (PBS), using an applied potential of +0.1 V vs. Ag/AgCl. In order 
to optimise the conditions the biosensor was immersed in a stirred buffer solution, the 
potential applied and sufficient time was allowed for a steady–state current to be obtained.  
The optimisation of each component in layer 2 was performed by measuring the 
amperometric response to the additions of glutamate over the concentration range of 7.5 µM 
to 100 µM glutamate. The variations in the quantities of the components are shown in Table 
1.  
After the optimisation of the NAD
+
 and CHIT components, the integration of additional 
0.01M Meldola’s Blue into each layer of the biosensor was investigated by amperometry.  
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Following optimisation of the individual biosensor components, studies into the effects of 
temperature and pH on the biosensor response were investigated. Optimum pH was 
determined by carrying out calibration studies over the pH range 5 – 9. A separate study was 
conducted to determine the optimum temperature. The temperature was varied over the range 
25 – 40°C with the pH fixed at 7. The optimisation of the temperature and pH is displayed in 
the supplementary material (supplementary Fig 1 & Fig 2 respectively). 
Table 1: This table displays combination of components found in layer 2. 
GLDH 
(Units) 
NAD
+
 (µg) CHIT (µg) 
27 13.5 5 
27 27 5 
27 54 5 
27 106 5 
27 214 5 
27 106 5 
27 106 10 
27 106 15 
27 106 20 
 
2.4.4. Application of optimised amperometric biosensor to the determination of 
glutamate in food.  
An OXO cube was prepared by dissolving one cube in 50 mL of phosphate buffer and 
sonicating for 15 minutes. The endogenous concentration of MSG was determined by using 
the method of standard addition. An initial 5µl volume of the dissolved OXO cube was added 
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to the stirred buffered solution (10 mL) in the voltammetric cell containing the biosensor, 
operated at +0.1 V (vs. Ag/AgCl) with subsequent standard additions of 3 µL of 25 mM 
glutamate. 
The reproducibility of the biosensor assay for MSG analysis in OXO cubes was determined 
by repeating the whole procedure five times with five individual biosensors.  
2.4.5. Application of optimised amperometric biosensor to the determination of 
glutamate in serum. 
The endogenous glutamate concentration of serum was determined by injecting an initial 
volume of 150 µL of serum into 9.85mL of buffer solution. Amperometry in stirred solution 
using an applied potential of +0.1V vs. (Ag/AgCl) was conducted with the serum solution. 
This was followed by additions of 3 µL aliquots of 25 mM standard glutamate solution to the 
voltammetric cell. The currents resulting from the enzymatic generation of NADH were used 
to construct standard addition plots, from which the endogenous concentration of glutamate 
was determined (n = 5). The reproducibility of the biosensor measurement was deduced by 
repeating the studies five times on a freshly diluted solution of the same serum with a fresh 
biosensor for each measurement. 
The procedure was repeated using 50µL of serum spiked with 1.5 mM glutamate (n = 5) to 
determine to the recovery of the assay.  
Due to the complex nature of the samples investigated, interferences such as ascorbic acid, 
sugars and other amino acids may be present. The possible effects of naturally occurring 
interferences from serum and OXO cubes were established using a dummy BSA biosensor. A 
dummy biosensor was constructed by drop coating the equivalent weight of the enzyme with 
BSA; however, no signals due to interfering substances were detected.  
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3. Results and Discussion 
3.1. Characterisation of the biosensor using scanning electron microcroscopy (SEM) 
and amperometry 
Figure 4 shows SEM images of the different layers deposited on top of the original Meldola’s 
Blue SPCE (MB-SPCE). The only treatment of the biosensor specimens was a drying 
procedure.  
Layer 1 (MWCNTs-CHIT-MB) is a porous open structure which shows the MWCNTs-CHIT 
deposited on the surface. The MB particles may be absorbed on both the exterior and interior 
of the MWCNTs.  
Layer 2 appears to consist of a more cohesive film covering the added components (GLDH-
NAD
+
-CHIT-MB). The possibility of utilising this structure as a biosensor for glutamate was 
investigated, however, the amperograms did not display steady state currents. From this we 
deduced that the cofactor (NAD
+
) and possibly the enzyme (GLDH) were not retained behind 
the film. This suggests that the film may actually be porous and that in solution the pores 
increase in size with egress of the biocomponents.  
Layer 3 shows a more compact structure and the underlying biosensor components are less 
visible than in layer 2. The biosensor comprising all 3 layers produced steady state responses 
to the addition of glutamate, indicating successful immbolisation of all the components.  
3.2. Hydrodynamic Voltammetry 
Hydrodynamic voltammetry was performed using the reagentless biosensor with 400 µM of 
glutamate in 0.75mM phosphate buffer (pH 7.0) containing 50mM NaCl. The optimum 
potential was considered to be +0.1V vs. Ag/AgCl (Fig 3) as this potential was situated on 
the plateau of the voltammetric wave.   
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3.3. Optimisation Studies 
Table 2: Performance characteristics of the glutamate biosensor fabricated with different 
masses of NAD
+
 and CHIT using a fixed quantity of GLDH.  
GLDH 
(Units) 
NAD
+
 (µg) CHIT (µg) Linear 
Range (µM) 
Sensitivity 
(nA/µM) 
27 13.5 5 25 – 50  0.035 
27 27 5 25 – 100 0.230 
27 54 5 25 – 75 0.238 
27 106 5 25 – 100 0.307 
27 214 5 25 – 50 0.238 
27 106 5 25 – 100 0.305 
27 106 10 7.5 – 105 0.315 
27 106 15 25 – 50  0.261 
27 106 20 Steady states 
not achieved. 
N/A 
Table 2 shows that the best performance for the glutamate biosensor was achieved with 106 
µg NAD
+
 and 10 µg of CHIT, together with 27U of GLDH in layer 2, in the absence of MB.  
It has been noted by [25], that with increasing concentrations of CHIT, the particle size of 
untreated MWCNT’s in aqueous solution is increased; consequently the larger particle size 
leads to increasingly entangled molecules of CNT/CHIT resulting in higher visocities. This 
change in visoscity would lead to a smaller diffusion coefficient, therefore leading to a 
decrease in the signal. This might explain why loadings of 15 and 20µg resulted in less 
sensitivity than 10µg in the present study. This also suggests that 5µg may not have 
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sufficiently bound the biological components, in comparison to 10µg of CHIT. Consequently, 
a CHIT loading of 10µg was selected for further studies.  
In order to asses the possibility of enchancing the effectiveness of the electron shuttling 
through the MWCNTs to the underlying MB electrode, the effect of adding  additional MB 
into these layers was investigated. It was found that the sensitivity was increased from 0.315 
nA/µM to 0.396 nA/µM and the linear range was unaltered. Consequently MB was 
incorporated into all layers of the biosensor for all further studies. 
3.4. Linear Range, Sensitivity, Detection Limit and Lifetime of Biosensor  
Figure 5A shows a typical amperogram obtained with the optimised biosensor for different 
concentrations of glutamate. The inset (Fig 5B) shows the resulting calibration plots which 
are linear over the range 7.5 – 105µM, the first calibration plot depicts Fig 5A; the detection 
limit was 3µM (based on n = 5, the coefficient of variation (CV) was 8.5%), based on three 
times the signal to noise, and the sensitivity was 0.39 nA/µM (based on n =5, the CV was 
6.37%). It should be noted that the biosensor possesses sensitivity relative to surface area of 
4.3µA/mM/cm
2
. This behaviour demonstrates the possibility of applying this device to food 
and biological samples.  
The life time of the biosensor in continuous operation is 2 hours, whilst the shelf lifetime is at 
least 2 weeks without any change in sensitivity. For the latter study, biosensors were stored in 
a desiccator which was stored in a fridge at 4°C. It should be mentioned that biosensors based 
on the cofactor NAD
+
 can be readily stabilised for over six months using commercially 
available enzyme stabilisers [26]. The life time of the biosensor was determined by 
calibration studies with known additions of glutamate in buffer (pH 7, 35°C). The sensitivity 
was then determined based on the slope of the subsequent calibration plots (n = 3). 
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3.5. Optimisation of Temperature and pH 
The optimum pH was determined by carrying out calibration studies over the pH range 5 – 9 
at a temperature of 25°C. The optimum pH was determined to be pH 7 as biosensors achieved 
the greatest sensitivity at this pH. A neutral pH also ensures that further studies investigating 
food and serum will not require the pH to be changed to achieve maximum sensitivity, 
thereby reducing sample preparation steps. A separate study was conducted to determine the 
optimum temperature. The temperature was varied over the range 25 – 40°C with the pH 
fixed at 7. The optimum temperature was determined to be 35°C. 
3.6. Application of the optimum amperometric biosensor (MWCNT–CHIT–
MB/GLDH–NAD–CHIT–MB/MWCNT–CHIT–MB) to the determination of 
glutamate in unspiked food.  
Many food products are known to contain MSG as a flavour enhancer, therefore, we decided 
to apply our new reagentless biosensor to determine glutamate in a known brand of beef 
stock cube.  
Standard addition was conducted by dissolving one OXO cube (5.9 g mass) in 50ml of PB 
and sonicating for 15 minutes until fully dissolved. Five replicate aliquots from this solution 
were analysed using fresh reagentless biosensors for each measurement. The determination 
was performed by adding an aliquot of PBS (9.95 mL) to the voltammetric cell, establishing a 
steady state current, and then injecting a 5µL volume of the OXO cube/PB solution into the 
cell. Sequential 3µL injections of 25 mM glutamate were then added to the cell, standard 
addition plots were constructed and from these the endogenous glutamate concentration was 
determined (n = 5). The mean quantity of glutamate recovered in unspiked OXO Cubes was 
90.6 mg/g, with a CV of 7.52%; results are shown in Table 3. A typical amperogram obtained 
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from the analysis of an OXO cube utilising the reagentless biosensor is shown in Figure 3 in 
the supplementary material.  
The average percentage of glutamate was calculated relative to the mass of an OXO cube and 
was found to be 18.1% (± 1.36%, n = 5). This compares favourably with a previously 
published value for MSG content in OXO cubes [7]. The quantity of glutamate recovered 
from the stock cube compares favourably with levels calculated with an optical biosensor, 
validated with HPLC [27] and utilising high performance thin layer chromatography [28]. 
The optical biosensor and HPLC analysis determined an L-glutamate level of 18.29% (± 
0.66%) and 17.70% (± 0.34%) based on n = 3, whilst the high performance thin layer 
chromatography technique determined a level of 133.50 mg/g (± 0.84%, n = 3). These values 
compare favourably to the values we have determined utilising the reagentless biosensor.  
 
 
 
 
 
Table 3: Quantity of glutamate determined in an unspiked beef OXO cube and in unspiked 
foetal bovine serum.  
OXO Cube 
Sample 
Quantity of Glutamate 
Recovered (mg/g) 
 
 Unspiked Foetal 
Bovine Serum 
Sample 
Concentration of Glutamate 
Detected  (mM) 
 
1 92.33  1 1.45 
2 91.48  2 1.60 
3 96.73  3 1.33 
4 94.83  4 1.30 
5 77.47 
 
 5 1.51 
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Mean (mg/g) 90.56  Mean (mM) 1.44 
Std Dev 6.81  Std Dev 0.12 
CV (%) 7.52 
 
 Cov (%) 8.54 
 
 
3.7. Application of the optimum amperometric biosensor (MWCNT–CHIT–
MB/GLDH–NAD–CHIT–MB/MWCNT–CHIT–MB) to the determination of 
glutamate in both unspiked and spiked serum. 
Amperometry, in conjunction with standard addition, was used to determine the endogenous 
levels of glutamate and the recovery for serum spiked with additional glutamate. The 
replicate serum samples were analysed using a fresh biosensor for each measurement. A 
typical amperogram obtained from the analysis of unspiked serum utilising the reagentless 
biosensor is shown in Figure 4 in the supplementary material. 
The data obtained on serum samples using the glutamate biosensor are shown in Table 3. The 
mean endogenous level of glutamate detected was 1.44 mM for the unspiked samples. The 
coefficient of variation was 8.54% for the five individual samples. This value is comparable 
to our previous publication [7] in which we report a value of 1.68 mM. It is worth noting this 
also compares favourably to a value discovered by a bioluminescence method [29]. 
The biosensors were then used to determine glutamate in spiked serum by fortifying with 
1.50 mM of glutamate. The results are shown in Table 4. The mean recovery (n = 5) was 
104% with a CV of 2.91%. 
Table 4: Recovery of glutamate detected in spiked serum fortified with additional glutamate.  
    
Sample Fortified 
Glutamate 
(mM) 
Endogenous 
Concentration 
(mM) 
Concentration of 
Glutamate Detected 
(mM) 
 
Recovery (%) 
1 1.50 1.44 2.96 101 
17 
 
2 1.50 1.44 3.01 105 
3 1.50 1.44 3.02 105 
4 1.50 1.44 2.97 102 
5 1.50 1.44 3.07 109 
     
Mean recovery 
(%) 
104    
Std Dev 3    
Cov (%) 2.91    
 
 
 
 
 
 
 
 
 
 
4. Conclusion 
This paper has described the successful development of a reagentless amperometric 
glutamate biosensor. This was achieved by incorporating the biocomponents using a layer-
by-layer procedure involving chitosan and MWCNTs. The device produced well defined 
steady state currents over extended operating times indicating that the bio-components are 
securely immobilised onto the base transducer.  
18 
 
The reagentless glutamate biosensor, fabricated in this study, is to date the first of its kind; 
our biosensor detection limit compares favourably to those previously reported for non-
reagentless glutamate sensors. The limit of detection of our biosensor  is  3 µM, whereas 
detection limits of 3.8µM, 10µM, 300µM, 5µM, 5µM, 20µM, 28µM and 50µM were reported 
by Alvarez-Crespo et al., 1997; Mizutani et al., 1998; Pasco et al., 1999; Schuvailo et al., 
2007; Tsukatani and Matsumoto, 2005; Ye et al., 1995, Monošík et al., 2013, Doaga et al., 
2009, respectively.  
The device and its components have been fully optimised to produce a reproducible 
reagentless biosensor which has been applied to the analysis of glutamate in clinical and food 
samples. Notably, the samples required no pre-treatment, other than dilution. The content of 
glutamate determined in OXO cubes and in serum compares favourably to that determined 
with our previous glutamate biosensor [7].  
This novel layer-by-layer approach to biosensor fabrication may hold promise as a generic 
platform for future biosensors based on dehydrogenase systems.  
It should be mentioned that the analysis of neuronal cells for changes in glutamate flux is of 
significant biomedical interest. High levels of glutamate leads to excitotoxicity, which is 
associated with diseases previously mentioned in the introduction. For potential future studies 
and applications, it is of value to consider how our biosensor compares to previously reported 
sensors which determine neuronal glutamate.  
Previously reported microelectrodes have been used to measure glutamate in vivo in rodent 
studies; these were fabricated by coating microelectrodes with glutamate oxidase (Burmeister 
and Gerhardt, 2003; Frey et al., 2010; Hu et al., 1994; McLamore et al., 2010; Qin et al., 
2008; Tian et al., 2009; Wassum et al., 2008). These required high operating potentials (+600 
- 700mV vs. Ag/AgCl), as the detection system involved the measurement of hydrogen 
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peroxide. High operating potentials can lead to the oxidisation of interferences such as 
ascorbic acid, which can interfere the measurement of glutamate. It is worth noting that 
Oldenziel et al., 2006, utilised a lower operating potential of +150mV vs. Ag/AgCl, by 
utilising the electron mediator horseradish peroxidase; which increased the complexity of 
biosensor fabrication.  
Microelectrodes coated with glutamate dehydrogenase are uncommon; this is likely due to 
the requirement of integrating the cofactor NAD
+
 onto the surface of the microelectrode 
without leeching, as mentioned previously. By miniaturizing our reagentless biosensor, the 
lower operating potential required to generate an analytical response would prove beneficial 
for the analysis of glutamate in real time, in neuronal cells. Our approach would negate the 
requirement for additional enzymes or use of charged membranes such as Nafion, to block 
out potential interferences. It should be feasible to incorporate the approach described in this 
paper into a implantable system by dip coating a carbon fibre electrode (10µM diameter) into 
formulation described in this paper.  
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 Figure and Scheme Captions 
Fig 1. A schematic diagram displaying the layer-by-layer drop coating fabrication 
procedure used to construct the reagentless glutamate biosensor, based on a MB-
SPCE electrode. 
Fig 2. Schematic displaying the interaction between the immobilized enzyme GLDH 
and glutamate at the surface of the electrode and the subsequent generation of the 
analytical response.  
Fig 3. Hydrodynamic voltammograms obtained using MB-SPCE/MWCNT-CHIT-
MB/GLDH-NAD
+
-CHIT-MB/MWCNT-CHIT-MB biosensor in the presence of 
400µM glutamate in 75mM phosphate buffer (pH 7.0) containing 50 mM NaCl. 
Fig 4. SEM imaging of each individual layer of the reagentless biosensor. The scale 
is the same for all SEM images. 
Fig 5. A) Amperogram conducted with the proposed final biosensor. Each arrow 
represents an injection of 3µL of 25mM glutamate in a 10mL stirred solution 
containing supporting electrolyte; 75mM, PB (pH 7.0), with 50mM NaCl at an 
applied potential of +0.1V vs. Ag/AgCl. 
              B) Calibration plots of five individually tested biosensors. The amperogram 
is depicted in the first calibration plot. 
 
Supplementary Figures  
Fig 1. Temperature study conducted over the range of 25 to 40°C. Values represent 
average currents generated at 30µM (n = 3). 
Fig 2. pH study conducted over the range of pH 5 to 9. Values represent average 
currents generated at 15µM (n = 3).  
Fig 3. Amperogram displaying the response obtained for unspiked OXO cube 
followed by two additions of 7.5µM glutamate. 75mM, PB (pH 7.0), with 50mM 
NaCl at an applied potential of +0.1V vs. Ag/AgCl. 
Fig 4. Amperogram displaying the response obtained for unspiked serum followed 
by two additions of 7.5µM glutamate. 75mM, PB (pH 7.0), with 50mM NaCl at an 
applied potential of +0.1V vs. Ag/AgCl. 
Fig 5. Photograph with scale of the final biosensors with insulating tape attached.   
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Highlights 
· First report on the fabrication of a reagentless amperometric glutamate 
biosensor using MWCNT’s.  
· High reproducibility, low cost due to screen printing and ease of use for real 
samples.       
· Detection limit of 3 μM, linear range; 7.5–105 μM and a sensitivity; 0.39 
nA/μM. 
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